Type 2 Diabetes Archive

Risk for Type 2 Diabetes, Cardiovascular Disease Elevated in Patients With Psoriatic Arthritis

Risk for Type 2 Diabetes, Cardiovascular Disease Elevated in Patients With Psoriatic Arthritis

Risk for type 2 diabetes, ischemic heart disease, and peripheral vascular disease was elevated among patients with psoriatic arthritis compared with the general population.

Lixisenatide Reduces Kidney Damage in T2D With Coronary Syndrome

Lixisenatide Reduces Kidney Damage in T2D With Coronary Syndrome

For patients with type 2 diabetes and acute coronary syndrome, lixisenatide can slow or prevent damage to the kidneys.

Insulins

Insulin products chart with pharmacokinetic properties.

Lorcaserin Reduces Risk for Incident Diabetes in Patients With Prediabetes

Lorcaserin Reduces Risk for Incident Diabetes in Patients With Prediabetes

In this new analysis, researchers looked at the long-term effects of the drug on diabetes prevention and remission in these patients.

Updated ADA, EASD Consensus Guidelines for Managing Hyperglycemia in T2D

Updated ADA, EASD Consensus Guidelines for Managing Hyperglycemia in T2D

Recommendations in the report highlight the importance of patient-centered decision making for glycemic management and improving diet and exercise for patients with T2D.

FDA Issues Safety Communication Regarding Pen Needle Use

FDA Issues Safety Communication Regarding Pen Needle Use

Standard pen needles have an outer cover and removable inner needle cover, while safety pen needles have an outer cover and a fixed inner needle shield that is not removed before an injection.

Obesity Reduces Number of Disease-Free Years Regardless of Lifestyle

Obesity Reduces Number of Disease-Free Years Regardless of Lifestyle

Obesity is associated with loss of disease-free years irrespective of position in the social hierarchy and lifestyle.

Basal Insulin Combination Therapies With Vildagliptin or Lixisenatide Equally Effective for T2D

Basal Insulin Combination Therapies With Vildagliptin or Lixisenatide Equally Effective for T2D

Combination therapies of basal insulin with either vildagliptin or lixisenatide are similarly effective at producing glycemic control improvements.

Genetics May Identify Type 2 Diabetes Subtypes

Genetics May Identify Type 2 Diabetes Subtypes

Clusters of type 2 diabetes loci and traits have been identified.

Sleep Disturbances Affect Glycemic Control in Patients With Type 2 Diabetes

Sleep Disturbances Affect Glycemic Control in Patients With Type 2 Diabetes

Findings from the study showed a graded association between shorter average sleep duration and higher HbA1c concentrations among participants with diabetes.

Replacing Red Meat With Poultry or Fish Lowers Type 2 Diabetes Risk

Replacing Red Meat With Poultry or Fish Lowers Type 2 Diabetes Risk

Substituting processed red meat with poultry or fish and replacing total red meat with fish were associated with a lowered risk for type 2 diabetes.

Investigating the Link Between Atrial Fibrillation and Type 2 Diabetes

Investigating the Link Between Atrial Fibrillation and Type 2 Diabetes

Compared with the general population, patients with type 2 diabetes are at a 35% to 60% greater risk for atrial fibrillation.

CPAP Therapy for Sleep Apnea Does Not Improve Diabetic Macular Edema in T2D

CPAP Therapy for Sleep Apnea Does Not Improve Diabetic Macular Edema in T2D

Continuous positive airway pressure for obstructive sleep apnea in patients with type 2 diabetes offered no improvement in visual acuity compared with usual care alone.

Time in Range According to CGM Associated With Diabetic Retinopathy

Time in Range According to CGM Associated With Diabetic Retinopathy

Investigators assessed the time in range according to a continuous glucose monitor and the risk for diabetic retinopathy.

Effect of Baseline Characteristics on Glycemic Control With Insulin Glargine in T2D

Effect of Baseline Characteristics on Glycemic Control With Insulin Glargine in T2D

Investigators examined the effects of insulin glargine 300 U/mL vs insulin glargine 100 U/mL on glycated hemoglobin, hypoglycemia, and body weight change.

Pharmacotherapy Personalization May Optimize Outcomes for Type 2 Diabetes

Pharmacotherapy Personalization May Optimize Outcomes for Type 2 Diabetes

Investigators examined patient factors that affect the use of diabetes medication in patients with type 2 diabetes.

Muscle Cell Profiles Relate to Exercise Response Variation in Type 2 Diabetes

Muscle Cell Profiles Relate to Exercise Response Variation in Type 2 Diabetes

Researchers aimed to determine whether variations in phosphocreatine recovery rates were marked by distinct epigenomic muscle profiles that could be seen prior to training.

High Prevalence of Obstructive Sleep Apnea Syndrome May Favor Screening in Diabetes

High Prevalence of Obstructive Sleep Apnea Syndrome May Favor Screening in Diabetes

The high prevalence of obstructive sleep apnea syndrome in both type 1 and type 2 diabetes may favor screening in these patients.

Update on the T2D-Dementia Link: Interview With Experts

Update on the T2D-Dementia Link: Interview With Experts

Endocrinology Advisor interviewed experts to explore mechanisms, clinical implications, and research needs pertaining to the diabetes-dementia link.

Estimated Prevalence of Diabetes in the United States

Estimated Prevalence of Diabetes in the United States

The prevalence of type 1 and type 2 diabetes is 0.5 and 8.5 percent, respectively, among U.S. adults.

Lower Hypoglycemia Risk, Greater Weight Loss With SGLT2 Inhibitor, Sulfonylurea in T2D

Lower Hypoglycemia Risk, Greater Weight Loss With SGLT2 Inhibitor, Sulfonylurea in T2D

SGLT-2i exhibited superior effects in terms of weight loss and did not increase the risk for hypoglycemia in dual therapy with sulfonylurea.

LVAD in Heart Failure Linked to Improved Glycemic Control

LVAD in Heart Failure Linked to Improved Glycemic Control

HbA1c levels following left ventricular assist device implantation were statistically significantly lower than before surgery.

Collaborative Care Improves Depression but Not Incident Diabetes

Collaborative Care Improves Depression but Not Incident Diabetes

Investigators examined the effects of a 12-month collaborative care program for patients with late-life depression on the 9-year incidence of diabetes in older individuals.

Association Between Urine Complement Proteins and Kidney Disease, Mortality in T2D

Association Between Urine Complement Proteins and Kidney Disease, Mortality in T2D

Researchers suggest complement pathway activation plays a role in diabetic kidney disease progression in people with proteinuria.

Rates of Incident Type 2 Diabetes in Chronic Kidney Disease

Rates of Incident Type 2 Diabetes in Chronic Kidney Disease

Investigators examined the rates and risk factors for type 2 diabetes in individuals with chronic kidney disease.

Availability and Affordability of Diabetes Medication Worldwide

Availability and Affordability of Diabetes Medication Worldwide

The affordability and availability of diabetes medications across multiple regions of the word were examined, along with the effects on the use of medications.

Intensive Blood Pressure Therapy Lowers Cardiovascular Risk in Diabetes

Intensive Blood Pressure Therapy Lowers Cardiovascular Risk in Diabetes

Intensive blood pressure therapy is associated with a significantly lower risk for serious cardiovascular events in the adults with diabetes.

Higher Aldosterone Levels Tied to Incident Type 2 Diabetes Risk

Higher Aldosterone Levels Tied to Incident Type 2 Diabetes Risk

Higher levels of aldosterone are associated with insulin resistance and incident type 2 diabetes among multiethnic individuals.

Early Treatment Intensification and Faster Glycemic Control in T2D

Early Treatment Intensification and Faster Glycemic Control in T2D

Individuals with type 2 diabetes intensifying within 12 months of the index date had a significantly shorter median time from intensification to glycemic control.

Comparing Second-Generation Basal Insulin Analogs for Type 2 Diabetes

Comparing Second-Generation Basal Insulin Analogs for Type 2 Diabetes

Researchers concluded noninferiority between two basal insulin analogs after comparing safety and efficacy end points.

Comparing Antidiabetic Drug Classes for Risk of Heart Failure

Comparing Antidiabetic Drug Classes for Risk of Heart Failure

The authors searched for randomized placebo-controlled trials (December 1, 2008 to November 24, 2017) involving 3 pharmacologic classes of antidiabetic medications to compare the effects of these agents on the risk of hospitalization for HF in T2DM patients.

Widespread Statin Use Not Recommended in Old, Very Old

Widespread Statin Use Not Recommended in Old, Very Old

Statin use is not associated with reduced risk of atherosclerotic cardiovascular disease or all-cause mortality among older adults without type 2 diabetes.

Trends in Cardiovascular Deaths for US Adults With and Without Diabetes

Trends in Cardiovascular Deaths for US Adults With and Without Diabetes

Investigators used data from the National Health Interview Survey and follow-up mortality data to estimate trends and disparities in CVD.

Comparing Efficacies of Second-Line Treatments in Type 2 Diabetes

Comparing Efficacies of Second-Line Treatments in Type 2 Diabetes

Researchers conducted a retrospective analysis to determine whether second-line treatment options sulfonylureas, DPP-4 inhibitors, and thiazolidinediones were associated with reduced HbA1c levels.

Polypharmacy Therapy for Schizophrenia Increases Risk for Type 2 Diabetes

Polypharmacy Therapy for Schizophrenia Increases Risk for Type 2 Diabetes

Investigators aimed to assess the effect of psychotropic medications, BMI, duration of schizophrenia, number of hospitalizations, and physical activity on the risk for T2D.

Effects of Early Glycemic Control on Future Type 2 Diabetes Complications

Effects of Early Glycemic Control on Future Type 2 Diabetes Complications

To determine the legacy effect of early glycemic control, researchers followed a cohort of 34,737 patients with newly diagnosed diabetes for an average of 13 years.

Vascular Risk Factors for Brain Calcification in Seniors Identified

Vascular Risk Factors for Brain Calcification in Seniors Identified

Diabetes and smoking are vascular risk factors associated with hippocampal calcification in older patients with memory issues.

WHO Issues Guidelines for Managing Diabetes in Low-Resource Settings

WHO Issues Guidelines for Managing Diabetes in Low-Resource Settings

WHO has developed guidelines for selecting therapy for treatment intensification in type 2 diabetes and on the use of insulin in type 1 and 2 diabetes in resource-poor settings.

Short-Duration Type 2 Diabetes Associated With Adverse Vascular Effects

Short-Duration Type 2 Diabetes Associated With Adverse Vascular Effects

Investigators examined carotid plaque composition and remodeling using magnetic resonance imaging in patients who were diagnosed with type 2 diabetes for a short duration.

Care Coordination Strategies Aid in Multiple Chronic Diseases

Care Coordination Strategies Aid in Multiple Chronic Diseases

Significant improvement for older adults with depression, COPD; diabetes, cardiovascular disease.

Medicaid Expansion Linked to Increase in Diabetes Prescription Fills

Medicaid Expansion Linked to Increase in Diabetes Prescription Fills

Researchers from the University of Southern California in Los Angeles examined the impacts of Medicaid expansion on access to diabetes medications.

FDA: Cases of Rare Gangrene of Genital Area Tied to Diabetes Drug Class

FDA: Cases of Rare Gangrene of Genital Area Tied to Diabetes Drug Class

The infection developed within several months of the patients starting SGLT2 therapy and the drug was discontinued in most cases. All patients required surgery and there was 1 reported death.

Evaluating Excess Risk for Heart Failure Hospitalization in Type 2 Diabetes

Evaluating Excess Risk for Heart Failure Hospitalization in Type 2 Diabetes

Investigators examined the excess risk for heart failure in patients with type 2 diabetes and compared the risk with that in the general population without diabetes.

The Relationship Between Hip/Knee Osteoarthritis and Risk for Incident Diabetes

The Relationship Between Hip/Knee Osteoarthritis and Risk for Incident Diabetes

Bilateral hip or knee osteoarthritis was significantly associated with a 16% to 25% increased risk for incident diabetes.

Assessing the Evidence of Aspirin for Primary Prevention in Diabetes

Assessing the Evidence of Aspirin for Primary Prevention in Diabetes

The substantial burden of cardiovascular disease in patients with diabetes has led to the exploration of various cardiovascular disease prevention strategies, including the use of aspirin.

High Prevalence of Diabetes in Patients With Severe Mental Illness

High Prevalence of Diabetes in Patients With Severe Mental Illness

Antipsychotic-treated patients with severe mental illnesses have a high prevalence of diabetes and prediabetes.

Examining Excess Risk Factors for Mortality, Cardiovascular Events in T2D

Examining Excess Risk Factors for Mortality, Cardiovascular Events in T2D

Investigators sought to determine whether excess risk factors for death and cardiovascular events in patients with type 2 diabetes could be reduced or eliminated.

Effect of Posttraumatic Stress Disorder and Obesity on Type 2 Diabetes

Effect of Posttraumatic Stress Disorder and Obesity on Type 2 Diabetes

In the absence of obesity, patients with PTSD are not at an increased risk for type 2 diabetes.

Clinical Characteristics Altering Risks and Benefits of Sulfonylureas and Thiazolidinedione Therapy in T2D

Clinical Characteristics Altering Risks and Benefits of Sulfonylureas and Thiazolidinedione Therapy in T2D

Investigators examined patterns of benefits and risks associated between the sex and BMI of different patient subgroups and sulfonylurea and thiazolidinedione therapies.

Weight Gain After Quitting Smoking May Increase Risk for T2D

Weight Gain After Quitting Smoking May Increase Risk for T2D

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality.

Bi-Directional Association Observed Between Obstructive Sleep Apnea and Diabetes

Bi-Directional Association Observed Between Obstructive Sleep Apnea and Diabetes

Clinical awareness of the bi-directional association may improve prevention and treatment of both diseases.

Bariatric Surgery Reduces Incidence of Microvascular Disease in Type 2 Diabetes

Bariatric Surgery Reduces Incidence of Microvascular Disease in Type 2 Diabetes

Investigators examined the effect of bariatric surgery and the incidence of microvascular complications in type 2 diabetes.

DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes

DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes

Investigators sought to determine whether the use of dipeptidyl peptidase-4 inhibitors is associated with the incidence of rheumatoid arthritis.

Healthy Lifestyle With Diabetes Cuts Cardiovascular Risk

Healthy Lifestyle With Diabetes Cuts Cardiovascular Risk

Greater adherence to an overall healthy lifestyle is associated with a substantially lower risk for cardiovascular disease.

Diabetes Treatments

Antidiabetic agents for the treatment of diabetes including maintenance and max doses.

Sitagliptin May Improve Glycemic Control Better Than Dapagliflozin in T2D With Mild Renal Insufficiency

Sitagliptin May Improve Glycemic Control Better Than Dapagliflozin in T2D With Mild Renal Insufficiency

The safety and efficacy of sitagliptin vs dapagliflozin in patients with type 2 diabetes and renal insufficiency was examined.

Intermittent vs Continuous Energy-Restricted Diet: Effects on Glycemic Control and Weight Loss T2D

Intermittent vs Continuous Energy-Restricted Diet: Effects on Glycemic Control and Weight Loss T2D

Intermittent energy restriction diet may be an effective alternative diet strategy for reducing HbA1c in patients with type 2 diabetes.

Second-Line Therapies Show Benefit Over Metformin Monotherapy in T2D

Second-Line Therapies Show Benefit Over Metformin Monotherapy in T2D

Investigators assessed the effect of second-line therapies on weight, HbA1c, and treatment persistence over 18 months in patients who had received metformin monotherapy.

Dapagliflozin Plus Omega-3 Carboxylic Acids for Non-Alcoholic Fatty Liver Disease in T2D

Dapagliflozin Plus Omega-3 Carboxylic Acids for Non-Alcoholic Fatty Liver Disease in T2D

Combination treatment with dapagliflozin plus omega-3 carboxylic acids may reduce fat content in nonalcoholic fatty liver disease.

One in Four Older Adults With Diabetes Uses Alternative Meds

One in Four Older Adults With Diabetes Uses Alternative Meds

More than 25 percent of older U.S. adults with diabetes use some type of complementary and alternative medicine.

HbA1c-Corrected FRAX Score May Better Predict Fracture Risk in Type 2 Diabetes

HbA1c-Corrected FRAX Score May Better Predict Fracture Risk in Type 2 Diabetes

A corrected HbA1C factor may improve the ability to predict the risk for fracture by the FRAX algorithm in T2D.

Estimating Risk Factors and Trajectories for Diabetic Polyneuropathy

Estimating Risk Factors and Trajectories for Diabetic Polyneuropathy

Investigators examined cardiometabolic risk factor trajectories in patients diagnosed with type 2 diabetes over the course of 13 years preceding diabetic polyneuropathy.

G6 CGM System Offers Improved Accuracy in Youth and Adults With Diabetes

G6 CGM System Offers Improved Accuracy in Youth and Adults With Diabetes

Investigators evaluate the performance of the G6 factory-calibrated continuous glucose monitoring system over 10 days.

Risk for Heart Failure Up in ALVSD Patients With Diabetes

Risk for Heart Failure Up in ALVSD Patients With Diabetes

For patients with asymptomatic left ventricular systolic dysfunction (ALVSD), those with diabetes have increased risk of heart failure development and hospitalization.

Diabetes Diagnosis May Impact Health Behaviors of Family

Diabetes Diagnosis May Impact Health Behaviors of Family

Partners of people with newly diagnosed diabetes have small but significant differences in health-related behavioral changes compared with partners of people without diabetes.

Detecting and Treating Depression in Diabetes

Detecting and Treating Depression in Diabetes

Comorbid depression, when not well controlled, can affect one's ability to self-manage diabetes. There can be loss of interest in making proper lifestyle choices, monitoring glucose levels, and taking one's medicines.

Hippocampal Calcification Associated With Aging, Diabetes, and Smoking

Hippocampal Calcification Associated With Aging, Diabetes, and Smoking

Investigators aim to identify risk factors for hippocampal calcifications and to investigate the relationship between hippocampal calcifications and cognitive function.

Risk for Diabetic Retinopathy With Incretin-Based Therapies

Risk for Diabetic Retinopathy With Incretin-Based Therapies

Investigators examined whether incretin-based therapies increase the risk for diabetic retinopathy compared with other antihyperglycemic agents.

Second-Line Sulfonylurea Therapy Linked to Cardiovascular Events in Type 2 Diabetes

Second-Line Sulfonylurea Therapy Linked to Cardiovascular Events in Type 2 Diabetes

Researchers assessed whether adding or switching to sulfonylureas is linked to increased risk for myocardial infarction, ischemic stroke, hypoglycemia, and all-cause mortality.

Diabetic Retinopathy May Be Independent Risk Factor for Parkinson Disease

Diabetic Retinopathy May Be Independent Risk Factor for Parkinson Disease

Results support that there is a relationship between diabetic retinopathy and Parkinson disease.

Characteristics of Severe Hypoglycemia Identified in T2DM

Characteristics of Severe Hypoglycemia Identified in T2DM

For patients with type 2 diabetes, characteristics of those with severe hypoglycemia include having a prior diagnosis of non-severe hypoglycemia and hemoglobin A1c (HbA1c) <6 percent.

PM2.5 Contributes to Burden of Diabetes Mellitus Globally

PM2.5 Contributes to Burden of Diabetes Mellitus Globally

Particulate matter (PM) with a diameter of less than 2.5 micrograms per cubic meter of air (PM2.5) makes a substantial contribution to the burden of diabetes.

Basal Insulin Analogs for Type 2 Diabetes Are Similar in Efficacy

Basal Insulin Analogs for Type 2 Diabetes Are Similar in Efficacy

A meta-analysis was conducted to examine the safety and efficacy of basal insulin analogs for type 2 diabetes.

Trulicity Labeling Updated to Include Data on T2D Patients With CKD

Trulicity Labeling Updated to Include Data on T2D Patients With CKD

In the AWARD-7 trial, patients who received Trulicity 0.75mg or 1.5mg in combination with mealtime insulin lispro achieved similar glycemic control with weight loss vs patients who received traditional basal-bolus insulin.

New Data Support Long-Term Cardiovascular Safety of Linagliptin in T2D

New Data Support Long-Term Cardiovascular Safety of Linagliptin in T2D

Results showed the overall safety profile of linagliptin in study patients, including adults with kidney disease, was consistent with previous data.

Severe Hypoglycemia in Type 2 Diabetes Linked to Poor Cognitive Outcomes

Severe Hypoglycemia in Type 2 Diabetes Linked to Poor Cognitive Outcomes

Adjustment of glucose-lowering medications in patients who are at high-risk for severe hypoglycemia may be beneficial to prevent mild cognitive impairment.

Canagliflozin Trial for T2D With CKD Stopped Early Due to Positive Results

Canagliflozin Trial for T2D With CKD Stopped Early Due to Positive Results

A clinical trial assessing canagliflozin (Invokana; Janssen) as an addition to standard-of-care in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) has been stopped early after meeting its pre-specified efficacy criteria.

Circadian System, Misalignment Have Distinct Impact on Insulin

Circadian System, Misalignment Have Distinct Impact on Insulin

The endogenous circadian system, behavioral cycle, and circadian misalignment have distinct effects on insulin sensitivity and β-cell function.

Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes

Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes

A retrospective, observational study was conducted to assess outcomes in patients with type 2 diabetes treated with second-generation basal insulin analogs.

Travel Costs Are Considerable Part of T2DM Follow-Up Costs

Travel Costs Are Considerable Part of T2DM Follow-Up Costs

For patients with type 2 diabetes mellitus (T2DM), travel costs relating to hemoglobin A1c (HbA1c) screening constitute a substantial cost item, and self-monitoring can reduce costs.

Link Between Oral Diabetes Medications and Bullous Pemphigoid

Link Between Oral Diabetes Medications and Bullous Pemphigoid

Finnish investigators evaluated the link between diabetes medications other than DPP-4 inhibitors and the risk for BP.

β-Cell Function in Youth With Impaired Glucose Tolerance, T2D

β-Cell Function in Youth With Impaired Glucose Tolerance, T2D

Investigators examined whether β-cell function can be improved or preserved with antihyperglycemic agents in young patients.

1996 to 2013 Saw Large Increase in Diabetes Spending

1996 to 2013 Saw Large Increase in Diabetes Spending

Increased spending per encounter has been the biggest driver of overall rise in spending.

Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes

Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes

Investigators examined the efficacy of low-dose aspirin in cancer chemoprevention in patients with diabetes.

Diabetes Risk Associated With Cirrhosis, Not Chronic HCV Infection, in HIV+ Patients

Diabetes Risk Associated With Cirrhosis, Not Chronic HCV Infection, in HIV+ Patients

Cirrhosis is associated with an increased risk for diabetes mellitus among patients living with HIV.

Dulaglutide Effective for Patients With T2D, Moderate to Severe CKD

Dulaglutide Effective for Patients With T2D, Moderate to Severe CKD

Glycemic control with once-weekly dulaglutide was similar to that with insulin glargine in patients with type 2 diabetes and moderate to severe chronic kidney disease.

Risk for Type 2 Diabetes May Be Increased With Comorbid Depression, Anxiety

Risk for Type 2 Diabetes May Be Increased With Comorbid Depression, Anxiety

Investigators examined the association between risk for T2D and comorbid depressive and anxiety symptoms.

Cardiovascular Disease Risk Lower in Women With Type 2 Diabetes

Cardiovascular Disease Risk Lower in Women With Type 2 Diabetes

Investigators examined gender differences in baseline characteristics and outcomes in patients with t2d and ASCVD.

Insulin Glargine 300 Safe, Effective in Seniors With T2DM

Insulin Glargine 300 Safe, Effective in Seniors With T2DM

Glargine 300 is associated with significantly lower annualized rates of documented symptomatic hypoglycemia than Gla-100.

Intensifying Treatment Does Not Negatively Affect Type 2 Diabetes

Intensifying Treatment Does Not Negatively Affect Type 2 Diabetes

Investigators assessed whether intensification of type 2 diabetes therapy affects health status and quality of life.

Thyroid Hormone Decreases Intrahepatic Lipid Content in Type 2 Diabetes

Thyroid Hormone Decreases Intrahepatic Lipid Content in Type 2 Diabetes

The role of low-dose levothyroxine to increase β-oxidation of fatty acids and decreases intrahepatic lipids in patients with type 2 diabetes was examined.

IDegLira: A Cost-Effective Alternative to Basal-Bolus Therapy in T2D

IDegLira: A Cost-Effective Alternative to Basal-Bolus Therapy in T2D

IDegLira is a cost-effective alternative to basal bolus insulin therapy with insulin glargine U100 plus insulin aspart.

ADA: T1D, T2D, GDM Before 26 Weeks Tied to Higher ASD Risk

ADA: T1D, T2D, GDM Before 26 Weeks Tied to Higher ASD Risk

Study shows increased risks of autism spectrum disorder in association with types 1, 2, gestational diabetes.

CAPPRI Scale is Feasible for Assessing Health-Related Quality of Life in Diabetic Distal Sensorimotor Polyneuropathy

CAPPRI Scale is Feasible for Assessing Health-Related Quality of Life in Diabetic Distal Sensorimotor Polyneuropathy

Investigators evaluated the performance of the CAPPRI in assessing health-related quality-of-life outcomes in patients with diabetic distal sensorimotor polyneuropathy.

Risk for Lactic Acidosis in Type 2 Diabetes Associated With Metformin Use

Risk for Lactic Acidosis in Type 2 Diabetes Associated With Metformin Use

Metformin use in patients with chronic kidney disease and the risk for lactic acidosis was examined.

Greater Deficits in Cognitive Function Examined in Diabetes

Greater Deficits in Cognitive Function Examined in Diabetes

Pen vs Patch Bolus Insulin Delivery for T2D Using CGM

Pen vs Patch Bolus Insulin Delivery for T2D Using CGM

Investigators compared 2 methods of delivering bolus insulin, pen vs patch, using metrics from continuous glucose monitoring.

Empagliflozin, Liraglutide Reduce Cardiovascular Mortality Risk

Empagliflozin, Liraglutide Reduce Cardiovascular Mortality Risk

Investigators conducted a meta-analysis to compare the efficacy of SGLT2i, DPP-4i, and GLP-1 agonists for reducing cardiovascular outcomes.

Type 2 Diabetes Does Not Affect Pneumonia Incidence, Outcomes After Stroke

Type 2 Diabetes Does Not Affect Pneumonia Incidence, Outcomes After Stroke

Investigators examined the incidence and outcomes of pneumonia in patients with acute ischemic stroke and type 2 diabetes.

Sign Up for Free e-Newsletters



CME Focus